Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma
2018; Springer Science+Business Media; Volume: 145; Issue: 2 Linguagem: Inglês
10.1007/s00432-018-2819-x
ISSN1432-1335
AutoresAlice Indini, Lorenza Di Guardo, Carolina Cimminiello, Michele Prisciandaro, Giovanni Randon, Filippo de Braud, Michele Del Vecchio,
Tópico(s)Melanoma and MAPK Pathways
Referência(s)